What's in Fundação Educacional Serra dos Órgãos's pipeline?

Fundação Educacional Serra dos Órgãos has 7 drugs in our index: 7 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Fundação Educacional Serra dos Órgãos's portfolio?

Top competitors by shared drug class: Ain Shams University, Başakşehir Çam & Sakura City Hospital, CHU de Quebec-Universite Laval, Dexa Medica Group, EMS.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/funda-o-educacional-serra-dos-rg-os.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Fundação Educacional Serra dos Órgãos — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fundação Educacional Serra dos Órgãos pipeline: 7 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

7 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Nucleotides + B12	Nucleotides + B12	marketed	Nutritional supplement / Vitamin combination		Hematology / Nutritional deficiency
Ethinyl Estradiol + Cyproterone acetate	Ethinyl Estradiol + Cyproterone acetate	marketed	Combined oral contraceptive with anti-androgenic activity	Androgen receptor (cyproterone acetate); estrogen receptor (ethinyl estradiol); gonadotropin suppression	Endocrinology / Gynecology
B Vitamins	B Vitamins	marketed	Vitamin supplement		Nutritional supplementation / General wellness
Z. officinale extract	Z. officinale extract	marketed	Herbal extract / Natural product		Gastroenterology / Anti-inflammatory
Aesculus hippocastanum, and associations	Aesculus hippocastanum, and associations	marketed	Herbal extract / Phlebotonic agent	Aescin (triterpene saponin); non-specific vascular and anti-inflammatory targets	Cardiovascular / Vascular disorders
Methenamine + Methylthioninium	Methenamine + Methylthioninium	marketed	Urinary antiseptic combination		Infectious Disease / Urology
Methenamine + Methylthioninium + Acriflavine + Atropa belladona	Methenamine + Methylthioninium + Acriflavine + Atropa belladona	marketed	Urinary antiseptic combination		Urology / Infectious Disease

Therapeutic area mix

Cardiovascular / Vascular disorders · 1
Endocrinology / Gynecology · 1
Gastroenterology / Anti-inflammatory · 1
Hematology / Nutritional deficiency · 1
Infectious Disease / Urology · 1
Nutritional supplementation / General wellness · 1
Urology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams University · 1 shared drug class
Başakşehir Çam & Sakura City Hospital · 1 shared drug class
CHU de Quebec-Universite Laval · 1 shared drug class
Dexa Medica Group · 1 shared drug class
EMS · 1 shared drug class
First Affiliated Hospital Xi'an Jiaotong University · 1 shared drug class
M.D. Anderson Cancer Center · 1 shared drug class
S.C.B. Medical College and Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fundação Educacional Serra dos Órgãos:

Cite this brief

Drug Landscape (2026). Fundação Educacional Serra dos Órgãos — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/funda-o-educacional-serra-dos-rg-os. Accessed 2026-05-17.